Life sciences legal forum

Our team cover: - The headline 2026 measures and their impact on workforce policies and operational models within life sciences organisations - Practical steps for in-house legal, HR, and compliance teams, including what to prioritise and where the key compliance and reputational risks lie - How to prepare for the major unfair dismissal reforms coming in January 2027, with guidance on early planning, risk mitigation, and the potential impact on employee relations.

This session is led by James Fry and he provides a clear, practical overview of: - Current transactional trends, including the structures that organisations are increasingly choosing to balance risk, flexibility and long term optionality - Developments in licensing approaches, with a look at how rights, milestones, royalties and governance are being shaped by today’s market expectations

In this webinar, we spotlight key procurement trends and the transformative effect of the Procurement Act 2023, which came into force earlier this year, and its impact on the life sciences industry.

Recorded 11 June 2025. This Life Sciences Legal Forum focuses on current trends for life sciences companies in early and later-stage financing transactions, mergers and acquisitions, and accessing capital markets. Our speakers look at trends in these types of corporate transactions across the industry, consider market norms in structuring and documenting transactions, and consider the options for growing companies, including considerations affecting the choice between US and UK markets.